Monitor for actual Form 4 filings confirming the sale. The pattern of consistent insider selling by a former officer, though small in absolute size, may weigh on sentiment. Watch for any acceleration in selling or additional insiders joining the trend.
ARVN drugs
ARVN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 8 $9.08entry
- T+1 · 2mo ago −3.52%α −3.06% · $8.76
- T+5 · 2mo ago −9.03%α −7.91% · $8.26
- T+20 · 6w ago −19.49%α −21.21% · $7.31
- T+49 · todayOpen
- T+60 · in 15d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Former officer Noah Berkowitz filed Form 144 notices to sell 8,300 shares of Arvinas common stock, valued at approximately $78,438, via option exercise. This follows prior sales of 30,000 shares in August and 24,000 shares in July 2026, indicating a consistent pattern of insider liquidation. The proposed sale is small relative to the $609M market cap, but the ongoing selling by a former officer may signal reduced conviction.
Key Facts
- Insider Noah Berkowitz (former officer) filed Form 144 to sell 8,300 shares of ARVN common stock.
- Estimated market value of proposed sale: $78,438.32 (based on ~$9.45/share).
- Sale is tied to exercise of options under a registered plan.
- Berkowitz previously sold 30,000 shares on 08/04/2026 ($264,000) and 24,000 shares on 07/09/2026 ($201,528).
- Total shares sold or proposed in the last two months: 62,300 shares (~$544k).
Financial Impact
Proposed sale of $78,438 (0.013% of market cap); cumulative recent sales ~$544k (0.09% of market cap).
Risk Factors
- Continued insider selling could undermine investor confidence.
- No current CEO/CFO buying to offset the selling signal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (ARVN), Batch item 1 | 0001950047-26-009128 |
| Document: 0001950047-26-009128-index.html | 0001950047-26-009128 |
| Document: 0001950047-26-009128.txt | 0001950047-26-009128 |
| 144 Filing (ARVN), Batch item 4 | 0001950047-26-009128 |
| Document: 0001950047-26-009128-index.html | 0001950047-26-009128 |
| Document: 0001950047-26-009128.txt | 0001950047-26-009128 |
Track record
21 reports on ARVN
6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +28.62% at T+60 after the Feb 23, 2026 report. 9 of 9 went positive at some point.
Filters
- Nov 3, 202613d ago S-3 Bearish 5/10 Entry $7.42 to $6.55 Now $6.77 +8.76% ▲ +11.73% +7.32% vs SPY
- Nov 3, 202613d ago 8-K Bearish 5/10 No price data
- Nov 3, 202613d ago Press Release Neutral 4/10 Entry $7.09 to $7.42 Now $6.77 −4.51% ▲ +4.65% +3.00% vs SPY
- Sep 4, 202610w ago 144 Neutral 3/10 Viewing Entry $9.08 to $8.76 Now $6.77 −25.44% ▼ −3.52% −3.06% vs SPY
- Jun 22, 202621w ago 8-K Neutral 3/10 Entry $8.14 to $8.05 Now $6.77 −16.83% ▼ −1.11% −1.06% vs SPY
- Jun 2, 202623w ago 8-K Bearish 6/10 Entry $7.70 to $7.74 Now $6.77 +12.08% ▼ −0.52% −0.12% vs SPY
- May 12, 202626w ago 8-K Mixed 6/10 No price data
- May 12, 202626w ago 8-K Bullish 7/10 Entry $9.57 to $9.87 Now $6.77 −29.26% ▲ +3.13% +2.56% vs SPY
- May 12, 202626w ago Press Release Bearish 8/10 Entry $9.57 to $9.87 Now $6.77 +29.26% ▼ −3.13% −2.56% vs SPY
- May 8, 202627w ago 144 Neutral 2/10 Entry $9.66 to $9.57 Now $6.77 −29.92% ▼ −0.93% −0.80% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers